Longitudinal Study of Aging in Mice: Serum Metabolomics

Closed Pre-Solicitation Posted

A later notice was posted: the Limited / Sole Source Justification from .

Solicitation number
75N95025Q06458
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories
Place of performance
Baltimore, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse (NIDA) and National Institute on Aging (NIA) intend to procure metabolomics analysis services for a longitudinal study of aging in mice, specifically requiring serum metabolomics analysis using mass spectrometry-based platforms. The procurement will be conducted as a non-competitive solicitation under FAR Part 13 Simplified Acquisition Procedures, targeting Emory University's Clinical Biomarkers Lab as the sole source vendor. The services involve metabolite measurement and data analysis of mouse serum samples, with deliverables including relative concentration profiles of small molecule entities and statistical analysis using techniques such as t-tests, ANOVA, and repeated measures analysis. Emory University was selected due to its unique capability to process samples with high specificity and sensitivity using only 15 microliters of serum volume, which is less than other available services require. The pre-solicitation notice was posted on September 8, 2025, with a response due date of September 23, 2025, and the anticipated award date is September 24, 2025.

This procurement does not utilize any set-aside designations and is classified under NAICS code 621511 (Medical Laboratories) with a size standard of $41.5 million. The contract value is not expected to exceed $250,000, positioning it within the simplified acquisition threshold that allows for single-source procurement. The performance timeline is estimated at 12-16 weeks from sample receipt, with the possibility of an extension of up to 8 additional weeks if needed. The National Institute on Aging will retain unlimited rights to all project deliverables produced under this contract. The procurement falls under PSC category B504 for Special Studies/Analysis - Chemical/Biological services, reflecting the specialized nature of the metabolomics research support required.

Notice text

PRE-SOLICITATION NOTICE OF INTENT

NON-COMPETITIVE

Solicitation: 75N95025Q06458

Title: Longitudinal Study of Aging in Mice: Serum Metabolomics

INTRODUCTION

PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION.   

THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). 

The National Institute on Drug Abuse (NIDA), National Institute on Aging (NIA) intends to intends to solicit by a request for quotation from Emory University – Clinical Biomarkers Lab for award on or around September 24, 2025.  The purpose of this purchase order will be to provide the National Institute on Aging (NIA) with metabolomics analysis.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 621511 – Medical Laboratories with a Size Standard of $41.5M.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses of the Federal acquisition Requlation (FAR) in effect through the current Federal Acquisition Circular (FAC).

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single Source provides that: For purchases not exceeding the simplified acquisition threshold,

Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).

DESCRIPTION OF REQUIREMENT

Purpose and Objectives

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute on Agign (NIA), has a requirement for metabolomics analysis.

This project requires an exhaustive metabolite profile of longitudinally collected serum

samples obtained from mice enrollled in longitudinal aging studies over several years.

Due to the limited volume that is able to be collected in these longitudinal studies only

15uL of serum is available for this analysis. This analysis will include generating a

relative concentration profile of all structurally named small molecule entities, which can

include both endogenous compounds, xenobiotics, and their metabolites, extracted from

the samples and detected by and established mass spec based metabolomics platform

and the statistical analysis of the resulting data, which typically consists of univariate

significance tests (ttests, ANOVA, repeated measures analysis, etc.).

Delivery or Deliverables

Please see the attached Statement of Work for further details.

CLOSING STATEMENT

THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.www.sam.gov.”

All responses must be received by Tuesday, September 23, 2025 at 9:00 a.m., Eastern Standard Time, and reference number 75N95025Q06458. Responses may be submitted electronically to Robin Knightly, Contract Specialist, at Robin.Knightly@nih.gov.

Fax responses will not be accepted.

Extensions to the deadline will not be granted.

Please contact Robin Knightly, Contract Specialist, at Robin.Knightly@nih.govor (301) 827-5302 with any questions.

Files

File Type Posted
B. SOW.pdf PDF

Notice history

Notice Type Posted
Longitudinal Study of Aging in Mice: Serum Metabolomics Latest Limited / Sole Source Justification
This notice Latest pre-solicitation Pre-Solicitation
Longitudinal Study of Aging in Mice: Serum Metabolomics Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
NIA:Non-Competitive Combined Synopsis/Solicitation NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
Quantitative Analysis of Longitudinal MR Images Bethesda, Maryland, United States · NAICS 541714 Office of Logisitics and Acquisition Operations No set-aside
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance Bethesda, Maryland 20892, United States · NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors